MANILA, Philippines — Food and Drug Administration (FDA) Director-General Eric Domingo hopes that a decision on the emergency use authorization (EUA) application of Johnson & Johnson’s COVID-19 vaccine can be made next week amid reports of blood clotting among those who have received it in the United States.
In an interview with INQUIRER.net’s INQside Look, Domingo said the national government’s vaccine expert panel was already scheduled to submit their recommendation on the vaccine on Wednesday. This was, however, delayed following reports on the effects of the J&J vaccines—including blood clots—in the United States.
“What they did was instead of giving the repor…
Keep on reading: FDA eyes decision on J&J jab’s EUA application by next week